Neurodegenerative Disease Research and Emerging Therapeutic Approaches for Slowing Progression and Enhancing Quality of
Neurodegenerative diseases are a group of disorders characterized by progressive loss of structure or function of neurons, leading to cognitive, motor, and behavioral impairments. Common conditions include Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS).
Current therapeutic strategies focus on symptom management, neuroprotection, and slowing disease progression. Pharmacological interventions may include cholinesterase inhibitors, dopaminergic agents, and neuroprotective compounds, while non-pharmacological approaches emphasize cognitive therapy, physical rehabilitation, and lifestyle modifications.
Recent advances in research explore gene therapy, stem cell treatments, immunotherapy, and disease-modifying drugs to target underlying pathological mechanisms. Early diagnosis through biomarkers, neuroimaging, and genetic testing is critical for effective intervention. Neurodegenerative disease management requires multidisciplinary care, integrating medical, psychological, and social support to enhance patient quality of life and prolong functional independence.